We are Sorry, This Page doesn't Exist
Gilead"s Second CAR-T Treatment Suffers the Same Issues as Yescarta
Approval of a second CAR-T cancer treatment faces the same setbacks holding back Yescarta salesRelated Stocks: GILD, CLLS,.....»»
Gilead"s (GILD) Harvoni and Descovy Get Approval in China
Gilead's (GILD) HCV drug Harvoni and HIV cocktail therapy Descovy get approval in China. Gilead Sciences, Inc. GILD announced that the National Medical P.....»»
Gilead, Novo Nordisk To Test Triple Combo Therapy In New NASH Study
Gilead Sciences Inc (NASDAQ: GILD) and Novo Nordisk A/S (NYSE: read more.....»»
Baird Analyst Says "Don"t Give Up" Yet On Gilead"s Remdesivir
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) fell Thursday afternoon in reaction to a disappointing report on an early readout for its remdesivir therapy, but investors should not "give up on this Latest Ratings fo.....»»
One Wall Street firm says approval for Gilead"s experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now (GILD)
AP Photo/Arek Rataj, File Gilead's experimental coronavirus treatment has a 50/50 chance at gaining approval at best, RBC Capital Markets analysts wrote Wednesday. The biotech company soared amid the late February downturn after a World Health Organiza.....»»
Small-Cap Biotechs Developing Novel Gene Therapies Could Become Targets of Big Pharma
The acquisition of Kite Pharmaceuticals by Gilead and Juno Therapeutics by Celgene may lead to more acquisitions of CAR-T gene therapy companiesRelated Stocks: GILD, NVS, CELG, MBIO, CYAD, CLLS, PFE, BLCM,.....»»
Intercept Pharmaceuticals is one step closer to getting FDA approval for the first-ever NASH drug
Intercept Pharmaceuticals Inc. announced Tuesday that a potential therapy for the fatty liver disease known as NASH had achieved its primary goal in a Phase 3 trial, a week after Gilead Sciences Inc. announced a competing trial had failed......»»
A Peninsula cell therapy company"s shares plunged 39% after its CEO resigned and the FDA raised manufacturing questions
Fardis had guided Iovance from being a little-know startup to the cusp of having an approved treatment. But the FDA request will set back its approval process by two years......»»
BioCryst receives UK approval of ORLADEYO therapy in HAE patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Everest: FDA grants granted accelerated approval of Trodelvy to Gilead
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead Sciences Stock Appears To Be Modestly Undervalued
Related Stocks: GILD,.....»»
United Therapeutics gets another FDA approval for pulmonary hypertension therapy
United Therapeutics (NASDAQ: UTHR) has received another Food and Drug Administration approval for Tyvaso more than a decade after the agency first approved the therapy for treatment of pulmonary arterial hypertension. The FDA approved a supplem.....»»
Gilead"s virology drug head named CEO of East Coast biotech AlloVir
Dr. Diana Brainard, a 10-year veteran of Gilead Sciences Inc. who currently heads up the company's broad virology drug pipeline, will take over as CEO of a young cell therapy company backed by her soon-to-be former employer. Starting May 17, Brain.....»»
Gilead, Merck to develop long-acting HIV therapy treatment, WSJ reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Regeneron"s therapy for rare heart disorder gets approved by FDA
Shares of Regeneron Pharmaceuticals Inc. were up 0.7% in premarket trading on Friday, the day after the company said it received regulatory approval in the U.S. for its ho.....»»
Gilead announces findings from a new analysis of the ZUMA-1 trial of Yescarta
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
GW Pharmaceuticals soars 46% after Jazz Pharma agrees to $7.2 billion acquisition of the medical-marijuana company
GW Pharma develops therapies derived from the marijuana plant, and was the first company to receive FDA approval for a cannabinoid-based therapy. Canada-based marijuana producer Aurora Cannabis pulled off a high sales volum.....»»